Trinity J. Bivalacqua
Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital, University of Pennsylvania
Papers
10
Total Citations
274
H-Index
8
About
Trinity J. Bivalacqua is a leading urologic oncologist whose research has fundamentally shaped the surgical management of prostate cancer, particularly through the optimization of radical prostatectomy techniques. His work provides critical, evidence-based comparisons between open, laparoscopic, and robotic approaches, demonstrating a sustained focus on improving patient outcomes. Bivalacqua’s landmark studies, such as his 2009 paper comparing surgical approaches (52 citations) and his 2013 work on nerve-sparing quality (46 citations), have established benchmarks for functional recovery and oncologic control. He has also addressed high-risk disease, showing in a 2013 study (44 citations) that minimally-invasive surgery can be effective for complex cases. Beyond technique, Bivalacqua has led impactful clinical trials, including the PREVENTER trial (2020, 37 citations) on pharmacologic prophylaxis for venous thromboembolism, and has critically examined the role of robotic surgery in urological oncology. His comprehensive 20-year institutional analysis of perioperative morbidity (30 citations) provides a longitudinal view of evolving surgical care. Through this body of work, Bivalacqua has not only advanced surgical precision but also prioritized patient safety and quality of life, making him a pivotal figure in modern urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Robotic surgery in urological oncology: patient care or market share?34 citations · 2014
- 6
- 7
- 8
- 9Open vs Robotic Cystectomy: Case Closed?4 citations · 2023
- 10